LION BIOTECHNOLOGIES INC - COM (LBIO)

CUSIP: 53619R102

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / COM
Total 13F shares
35,495,544
Share change
+9,608,531
Total reported value
$325,493,367
Put/Call ratio
205%
Price per share
$9.17
Number of holders
85
Value change
+$86,742,239
Number of buys
73
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP 53619R102?
CUSIP 53619R102 identifies LBIO - LION BIOTECHNOLOGIES INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LION BIOTECHNOLOGIES INC - COM (LBIO) as of Q2 2015

As of 30 Jun 2015, LION BIOTECHNOLOGIES INC - COM (LBIO) was held by 85 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,495,544 shares. The largest 10 holders included FMR LLC, venBio Select Advisor LLC, Ayer Capital Management, LP, PERCEPTIVE ADVISORS LLC, FRANKLIN RESOURCES INC, BAKER BROS. ADVISORS LP, Broadfin Capital, LLC, RS INVESTMENT MANAGEMENT CO LLC, QVT Financial LP, and VANGUARD GROUP INC. This page lists 85 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.